Surgery Partners, Inc.SGRYNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank69
3Y CAGR-40.2%
5Y CAGR-15.8%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-40.2%/yr
vs +91.8%/yr prior
5Y CAGR
-15.8%/yr
Recent deceleration
Acceleration
-132.0pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 38.89% |
| Q3 2025 | -813.71% |
| Q2 2025 | 93.43% |
| Q1 2025 | 65.12% |
| Q4 2024 | -244.00% |
| Q3 2024 | -108.33% |
| Q2 2024 | -21.95% |
| Q1 2024 | -1130.00% |
| Q4 2023 | -102.76% |
| Q3 2023 | 93.33% |
| Q2 2023 | 1462.50% |
| Q1 2023 | -95.83% |
| Q4 2022 | 182.14% |
| Q3 2022 | -264.71% |
| Q2 2022 | -65.31% |
| Q1 2022 | 40933.33% |
| Q4 2021 | 99.57% |
| Q3 2021 | 28.21% |
| Q2 2021 | -2.63% |
| Q1 2021 | -280.00% |
| Q4 2020 | 92.06% |
| Q3 2020 | -88.06% |
| Q2 2020 | -17.54% |
| Q1 2020 | -50.00% |
| Q4 2019 | -18.75% |
| Q3 2019 | 21.95% |
| Q2 2019 | 2.38% |
| Q1 2019 | 86.32% |
| Q4 2018 | -597.73% |
| Q3 2018 | -7.32% |
| Q2 2018 | -10.81% |
| Q1 2018 | 44.78% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -54.83% |
| Q1 2017 | -117.14% |
| Q4 2016 | 818.86% |
| Q3 2016 | -221.72% |
| Q2 2016 | 126.67% |
| Q1 2016 | -142.86% |